Skip to main content
. Author manuscript; available in PMC: 2019 Aug 6.
Published in final edited form as: JAMA Neurol. 2019 Mar 1;76(3):318–325. doi: 10.1001/jamaneurol.2018.3746

Figure 3. Neurofilament Light Protein in Participants With Autopsy-Verified Neurodegenerative Diseases.

Figure 3.

Neurofilament light levels in clinically diagnosed control participants are added as a dotted line for reference. The graph omits outlier data points (neurofilament light levels >5000 pg/mL) for 1 participant with frontotemporal lobe degeneration and 2 with amyotrophic lateral sclerosis.